External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination
Top Cited Papers
- 1 January 2015
- journal article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 68 (1), 25-34
- https://doi.org/10.1016/j.jclinepi.2014.09.007
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell TransplantationTransplantation and Cellular Therapy, 2011
- Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reportingBMC Medicine, 2011
- Reporting performance of prognostic models in cancer: a reviewBMC Medicine, 2010
- Reporting methods in studies developing prognostic models in cancer: a reviewBMC Medicine, 2010
- PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancerBreast Cancer Research, 2010
- Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic reviewCritical Care, 2009
- Model for predicting short-term mortality of severe sepsisCritical Care, 2009
- Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort studyBMJ, 2007
- Prediction of mortality among emergency medical admissionsEmergency Medicine Journal, 2006
- New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study GroupJournal of Clinical Oncology, 2002